ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

UC Davis Becomes 41st Center to Earn NCI Comprehensive Designation

March 16, 2012

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005

CCI Will Tackle Reimbursement Issue

May 16, 1980

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006

CMS Abandons Proposal To Require Further Certification Of Clinical Trials For Coverage.

October 19, 2007